In the present study, we investigate the mechanism of how p53 induces growth arrest in Rb-defective Saos2 cells that express temperature-sensitive mutant p53 (ts p53). The activation of p53 at a permissive temperature (32.58C) induces the cell cycle arrest at both the G1 and G2 stages. The induction of several p53-responsive genes as well as a small form of p130 (S-p130) was detected upon p53 activation. S-p130 retained the functions as a pocket protein and was dominant over p130 at the protein level after 36 h at 32.58C. A canonical p53 binding site was identified in intron 4 of p130. Furthermore, a novel p53-inducible transcript containing a partial intron 4 sequence downstream of the p53 binding site and exon 5 of p130 was detected by RT -PCR, suggesting S-p130 is induced by p53 at transcriptional level. The results from gel shift assay and immunoprecipitation showed that Sp130 as well as p130 formed complexes with both E2F1 and E2F4 at a permissive temperature. Moreover, the transient expression of E1A (12S) and E2F1 effectively abrogated p53-induced cell cycle arrest. These results strongly suggested that p130 and its truncated form might substitute Rb in mediating p53-induced cell cycle arrest in Rb 7/7 Saos2 cells.
Introduction p53 is such an important tumor suppressor that its defectiveness is associated with more than 50% of human cancers. As a guard of the genome, p53 senses DNA damage and induces cell cycle arrest, DNA repair and apoptosis (Levine, 1997) . It is well established that p53 induces cell cycle arrest, at least in part, by transactivating p21 waf1 and 14-3-3 s (El- Deiry et al., 1993; Waldman et al., 1995; Deng et al., 1995; Hermeking et al., 1997) . p21 waf1 is a cyclindependent kinase (CDK) inhibitor which inhibits the phosphorylation of Rb protein by CDKs (Harper et al., 1993; Xiong et al., 1993; Sherr and Roberts, 1999; Lees et al., 1991; Kato et al., 1993; Kitagawa et al., 1996) . The hypophosphorylated or unphosphorylated Rb forms complexes with E2F family transcription factors and prevents the transactivation of genes that are necessary for S phase entry, leading to cell cycle arrest in the G1 phase (reviewed by Dyson, 1998; Nevins, 1998) . The induction of p21 also inhibits cyclin B/CDC2 and cooperates with 14-3-3s to mediate G2 arrest (Chan et al., 2000) .
E2F transcription activators play a pivotal role in mediating gene expression during cell proliferation. There are six members of the E2F family proteins, E2F1, E2F2, E2F3, E2F4, E2F5 and E2F6 (reviewed by Dyson, 1998) , that form complexes with the DP family proteins. Promoters containing E2F binding sites include genes encoding S phase regulatory proteins such as DNA polymerase b, thymidylate synthase, proliferating cell nuclear antigen, and ribonucleotide reductase, as well as genes regulating cell cycle progression such as those encoding cyclin A, cyclin E, cdc2 and c-myb (Hurford et al., 1997; Degregori et al., 1995) . Although all the E2F family proteins bind to the same consensus sequence in vitro, different E2F heterodimers might activate a particular set of genes and play distinct roles in cell cycle regulation (Tao et al., 1997; Degregori et al., 1997; Takahashi et al., 2000) . Furthermore, E2F members also differ in their activity in binding to Rb family proteins.
The Rb protein family contains Rb and its related proteins, p107 and 130/Rb2 (reviewed by Nevins et al., 1998; Harbour and Dean, 2000; Classon and Dyson, 2001) . While Rb preferentially binds to E2F1, E2F2 and E2F3, as well as E2F4 and E2F5 in some cases, p107 and p130 bind mainly with E2F4 and E2F5 (Li et al., 1993; Cobrinik et al., 1993; Ginsberg et al., 1994; Hijmans et al., 1995; Vairo et al., 1995) . The Rb complexes with E2F1, E2F2 or E2F3 have been implicated in G1 arrest. The p130/E2F4 complex was associated with the control of G0/G1 transition , whereas the function of p107/E2F4, E2F5 complexes that are found mainly in cycling cells is not clear. Although there is a similarity among the Rb family proteins, only Rb is frequently involved in tumorigenesis. It was reported that Rb was essential for DNA damage-induced cell cycle arrest (Harrington et al., 1998) . However, the ectopic expression of p53 as well as p21 induces cell cycle arrest in p53 7/7 and Rb
7/7
Saos2 cells (Diller et al., 1990; Yamato et al., 1995; Bates et al., 1998; Chen et al., 1996) . The p21 suppresses cell growth and E2F activity in cells lacking a functional Rb protein (Dimri et al., 1996) . Furthermore, ectopic expression of p130 or p107 also induced cell cycle arrest in Saos2 cells (Claudio et al., 1996) . These reports raised the possibility that Rb may be dispensable for p53-induced cell cycle arrest, although the mechanisms remain to be elucidated. In this study, we investigated the mechanism of how the expression of temperature-sensitive (ts) p53 induces cell cycle arrest in Rb-defective Saos2 cells. The results showed that (ts) p53-induced cell cycle arrest was associated with decrease of p130 and production of a small form of p130 (S-p130) which was suggested to be translated from a new transcript induced by wild-type activity of p53. At a permissive temperature both the original and truncated forms of p130 can bind to E2F1 and E2F4, as demonstrated by immunoprecipitation and gel shift assay. These results suggest that p130 and its truncated form, both of which form complexes with E2F1 or E2F4, mediate p53-induced cell cycle arrest in Saos2 cells.
Results

Activation of p53 induces reversible cell cycle arrest in both the G1 and G2 phases
The activation of p53 induces either cell cycle arrest or apoptosis, depending on cell types. Previously, we reported that the expression of temperature-sensitive mutant p53 (p53Val138) induced cell cycle arrest in both G1 and G2 phases at a permissive temperature (32.58C) (Yamato et al., 1995) . In this study, we employed one of the clones, S138V, to investigate the detailed mechanism of how p53 induces cell cycle arrest in Rb-defective cells. To further characterize p53-induced cell cycle arrest, we performed FACS analysis on S138V cells cultured at the non-permissive or permissive temperature for various times (Figure 1) . The results showed that the cell population in S phase dropped from 29.5 to 14.8% at 24 h, and to 8.5% at 48 h after temperature shifting. The cell population in the S phase did not change significantly in Sneo cells that contain the CMV vector when cultured at 32.58C (data not shown). When arrested cells were shifted back to non-permissive temperature, the S phase population increased, suggesting that p53-induced cell cycle arrest is reversible. The cells cultured at permissive temperature showed enlarged and flattened morphology that was similar to Saos2 cells exogenously expressing Rb protein (data not shown).
Induction of a truncated form of p130 upon p53 activation
To elucidate the pathway by which p53 induces cell cycle arrest, we analysed the expression levels of p53 downstream of the targets and the phosphorylation status of Rb family proteins by Western blotting. The result showed that the induction of both p21 and MDM2 was detected at 3 h and peaked at 6 h after the temperature shift-down. Consistent with the reversible growth arrest, the induction of p21 and MDM2 was also reversible. When cells which had been cultured at the permissive temperature for 18 h were transferred back to the non-permissive temperature for 18 h, the induction of both p21 and MDM2 proteins became undetectable (Figure 2 ).
Rb family proteins mediate growth arrest by forming complex with E2F family transcription factors through their hypo-or un-phosphorylated form. Consistent with the previous reports that Rb was defective in Saos2 cells, we failed to detect Rb protein in S138V cells (data not shown). When cells were transferred to the permissive temperature, the protein level of p130 decreased, which was accompanied by the induction of a fast-migrating band around 105 kDa (short form of p130, S-p130) and S-p130 increased at least to 36 h (Figure 2 ). Another member of the Rb family, p107, did not change either at the protein level or in the migration rate in gel electrophoresis upon p53 activation.
S-p130 was detected by both anti-p130 antibody (C20) raised against the C-terminal peptide of p130 (amino acids 1063 -1082) and anti-Rb-2 (p130) raised against the N-terminal region of p130 (amino acids 26 -367). But the reactivity to the N-terminal side antibody (shown as N367 in Figure 3 ) was weaker than Figure 1 p53 induces cell cycle arrest at G1 and G2/M in Saos2 cells. Saos2 cells expressing temperature-sensitive p53 (S138V) or vector (Sneo) were cultured at the non-permissive temperature (H) or at the permissive temperature for 24 h (L24) or 48 h (L48) or first cultured at the permissive temperature for 24 h and then shifted back to the non-permissive temperature for 24 h (L244H24). The cells were harvested and the cell cycle distribution was determined by FACS analysis p130 mediates p53-induced cell cycle arrest C-F Gao et al that to the C-terminal antibody, suggesting that this band may have lost a part of the N-terminus of p130 (the top panel). S-p130 was also detected in K138V (K562 cells expressing exogenous tsp53val138 mutant) cells cultured at permissive temperature (middle panel) and in Saos2 cells infected with adenovirus harboring the wild-type p53 (the bottom panel), suggesting that p53-induced production of S-p130 was not limited to the cell type of Saos2 or to the tsp53 gene.
Since the faster migration of a protein on SDS -PAGE might result from dephosphorylation, we examined whether the treatment of p130 with lphosphatase could produce S-p130. P130 was immunoprecipitated from cell lysates prepared from cells cultured at the permissive or non-permissive temperature, to remove phosphatase inhibitors. The precipitates were treated with l-phosphatase and analysed by Western blotting. The results clearly showed that l-phosphatase dephosphorylated both p130 and S-p130. However, the sizes of these two dephosphorylated forms were completely different (Figure 4, top panel) . This experiment excluded the possibility that the S-p130 was a dephosphorylated form of p130.
Rb family proteins contain pocket domains that were originally defined as the regions necessary for their interaction with adenovirus E1A or simian virus SV40 T antigen (Chellappan et al., 1992; Knudsen and Wang, 1998; Li et al., 1993) . To further confirm that Sp130 retains the character of Rb family proteins, we examined its ability to bind to T-antigen or E1A protein. Purified T-antigen was incubated with cell lysates from S138V cells cultured at the permissive or non-permissive temperature to allow its binding to p130. The lysates were immunoprecipitated with anti-T-antigen antibody and analysed by Western blotting with anti-p130 antibody. The results showed that Tantigen bound to both p130 and S-p130 ( Figure 4 , middle panel). To examine the interaction between E1A and S-p130 protein, we incubated the cell lysates Figure 2 Reversible induction of p53-responsive gene products and the truncated p130 (S-p130) in S138V cells. Cells were cultured at the permissive temperature for the indicated times or first cultured at the permissive temperature for 18 h, then shifted back to the non-permissive temperature for another 18 h (LH). The cells were collected and subjected to Western blot analysis with the following antibodies: MDM2 (SMP14), anti-p21 (C-19), anti-p53 (PAb1801), p130 (C-20), anti-p107 (C-18). The arrow indicates truncated p130 (S-p130) Figure 3 The truncated form lost the N-terminal portion of p130. S138V cells (upper panel) or K138V cells (middle panel) were cultured at the permissive (L) or non-permissive (H) temperature for 24 h. Bottom panel: Saos2 cells were infected with adenovirus (Ad) or adenovirus harboring wild-type p53 (Ad/ p53) for 48 h. Cells were collected and analysed by Western blotting with p130 antibody (C-20) or N-terminal antibody (N367) Figure 4 Characterization of truncated p130 by its phosphorylation and interaction with virus oncoprotein. Upper panel: p130 short form is not produced by dephosphorylation of original p130. S138V cells were cultured at the non-permissive (H) or permissive temperature (L) for 24 h. The cell lysates were immunoprecipitated with anti-p130 antibody (C-20) as described in Materials and methods to remove phosphate inhibitor. The immunoprecipitates were treated with l-phosphatase (New England Biolabs, Inc, MA, USA) as recommended by the supplier (lPpase+) or without treatment (l-Ppase7). The p130 precipitates and the original cell lysates (straight W.B.) were analysed by Western blotting with anti-p130 antibody (C-20). Middle panel: the truncated p130 (S-p130) binds to SV40 T-antigen. Lysates (20 mg) from S138V cells cultured at the non-permissive (H) or permissive (L) temperature were incubated with 1 mg purified SV40 T-antigen. The SV40 T-antigen complexes were immunoprecipitated with anti-T-antigen antibody and analysed by Western blotting with p130 antibody (C-20). Bottom panel: p130 were co-precipitated with E1A from a mixture of S138V and E1A expressing 293 cell lysate from S138V with those from 293 cells that expressed E1A protein. The E1A complex immunoprecipitated with anti-E1A antibody was analysed with anti-p130 antibody. The results showed that both forms formed a complex with the E1A protein ( Figure 4 , bottom panel). These data indicated that S-p130 is a truncated form of p130 that retains the functional pocket domain.
S-p130 was induced at a transcriptional level
To explore the possibility that S-p130 might be induced by wild-type activity of p53 at the transcriptional level, we investigated the sequences of the p130 promoter and N-terminal introns. Based on the genomic sequence (access number NT_010498, Bac clone RP11-182C10), a tandem repeat of a potential 10 bp p53 binding sequence (p53BS) was found which had 90% homology with the consensus sequence (p53CBS), located between 71682 and 71701 in the intron 4 (the first 5' base of the exon 5 was denoted to be +1). We then examined whether or not the putative p53BS found in the intron 4 was functional. Three different reporter luciferase plasmids were constructed, which include 30 nucleotides covering the p53BS in the intron 4 [p53BS-(W)-Luc, its mutant form p53BS-(M)-Luc, and I 4 -Luc] ( Figure 5A ). When these plasmid DNAs were transfected into S138V cells and then incubated at the two temperatures, the luciferase was activated in cells at the permissive temperature but not at the nonpermissive temperature with reporter plasmids which contained the wild-type p53BS, but not the mutant p53BS ( Figure 5B ). These results suggested that the p53BS could function to stimulate transcription by responding to the wild-type activity of p53.
Next, we examined whether or not a new p130 transcript was synthesized in p53 dependent manner. We set up two forward PCR primers in the intron 4, I 4U and I 4D , upstream and downstream, respectively, of the p53BS and one reverse primer of E 5 in the exon 5. As shown in Figure 6A , the E 5 -I 4D primer set produced a 395 bp fragment that was amplified from cDNA made from S138V cells cultured at the permissive-temperature but not at the non-permissive temperature, while no PCR product was detected when the I 4U -E 5 primer set was used. In addition, the nucleotide sequence of the 395 bp fragment was determined and found to be comprised of the predicted parts of the intron 4 and exon 5. Further, there was no wild-type-specific p53-dependent increase of PCR products when each primer of introns 1, 2 and 3 was PCR-amplified with E 5 (data not shown). These results suggest that a new p130 RNA transcript was synthesized, which contained the region between I 4D and the splicing acceptor site of the exon 5. To further confirm the p53-dependent synthesis of the transcript, Figure 5 Identification of p53-responsive sequence in p130 genes. (A) Partial genomic structure of p130 between exon 4 (E 4 and exon 5 (E 5 ). The p53 binding sequence (p53 BS) and the p53 consensus binding sequence (p53 CBS) are shown above. R, purine. W, A/T. Y, pyrimidine. | indicates the match between p53 consensus binding sequence and p53 binding sequence, in p130 intron 4. The constructs that contain p53-responsive sequence (I 4 -Luc, p53BS(W)-Luc) and its mutant form (p53BS(M)-Luc) were used for luciferase analysis. (B) Luciferase assay. The p53 binding sequences shown in (A) were constructed into PGL3-promoter vector as described in Materials and methods. S138V cells were transfected with the indicated constructs and cultured at the permissive temperature (L) or non-permissive temperature (H). The luciferase activity was measured after 24 h Figure 6 Induction of a new p130 transcript. (A) Total RNA was isolated from S138V cells cultured at the permissive (L) or non-permissive (H) temperature for 24 h. RT -PCR was performed with the indicated primers as described in Materials and methods. M indicates 100 bp DNA marker. (B) Total RNA was isolated from S138V or Sneo cells cultured at the permissive temperature for the indicated times. RT -PCR was performed using the three primers: E 2 , I 4D and E5. The products amplified from p130 and truncated form of p130 mRNAs are indicated. M indicates DNA marker of jX174 RF DNA HaeIII digests p130 mediates p53-induced cell cycle arrest C-F Gao et al cDNAs were prepared from S138V cells incubated for various times at the permissive temperature. In addition, PCR amplification was performed together with the E 2 -E 5 exon primer set which showed 487 bp band and was used as an internal control of the intact p130 species ( Figure 6B ). The 395 bp fragment was detected after the temperature shift-down of S138V cells and increased for at least 24 h, but not detected with Sneo cells, suggesting that synthesis of the new transcript is dependent on the wild-type activity of p53 and the kinetics of the increase was similar to that of S-p130 protein.
A possibility was thus suggested that Sp130 was translated from the new transcript induced by wild-type activity of p53 at the permissive temperature.
Both p130 and S-p130 form complexes with E2F1 upon shifting to the permissive temperature
The Rb family proteins regulate cell cycle progression by scavenging and forming repressor complexes with E2F family proteins. To investigate the biological roles of p130 and S-p130 in p53-induced cell cycle arrest, we examined their interaction with E2F family proteins and cyclin A and cyclin E, which are known to bind to p130. Lysates from S138V cells cultured at the nonpermissive or the permissive temperature for 24 h were immunoprecipitated with antibodies against E2F1, and E2F4 or cyclin A, and cyclin E and analysed by Western blotting with anti-p130 or p107 antibodies ( Figure 7A ). The results showed a significant binding of p130 to E2F4 or cylin A, but much less to E2F1 or cyclin E at the non-permissive temperature. At the permissive temperature, both p130 and S-p130 showed strong binding to E2F1 in addition to E2F4, but the binding of cyclin A to p130 or S-p130 was weak or non-existent, respectively. P107 showed binding to E2F4, cyclin A or cyclin E at the non-permissive temperature and the binding decreased at the permissive temperature. At 48 h after the temperature shifting, there was more E2F1 bound to S-p130 than to p130 ( Figure 7B ). Identical results were obtained with different antibodies against E2F1 (KH95 or C-20) or E2F4 (C108 or C20). When anti-p130 antibody was used for immunoprecipitation, higher levels of both E2F1 and E2F4 were detected in the precipitates from cells cultured at the permissive temperature than at the non-permissive temperature ( Figure 7C ). We failed to detect any significant binding of p130 to other members of the E2F family (data not shown). Consistent with a previous report that p21 disrupts the complex between p130 and cyclin A, E/CDK2 (Shiyanov et al., 1996) , we detected extensive binding of p21 to the cyclin A/CDK2 at the permissive temperature (Figure 8 ). Both p130 and p107 were released from the cyclin A/CDK2 complex formed at the non-permissive temperature, suggesting that the release of p130 from the p130/cyclin A/CDK2 complex and/or associated dephosphorylation might have contributed to its increased binding to E2F1. The binding of p130 to cyclin D, cyclin E, CDK4 or CDK6 was undetectable at both temperatures.
P130 is the only Rb family protein that binds to E2F1 at the permissive temperature
In order to further explore the role of p130 in p53-induced growth arrest, we analysed the p130/E2Fs complex using Gel Mobility Shift Assay (EMSA) using an end-labeled E2F consensus oligonucleotide as a probe. Three major E2F-containing complexes designated as A, B and C were detected in extracts from Sneo cells or S138V cells ( Figure 9A ). The complexes did not change significantly in Sneo cells cultured at the non-permissive temperature or at the permissive p130 mediates p53-induced cell cycle arrest C-F Gao et al temperature for various times. However, complex A and C decreased and complex B increased dramatically in S138V cells after the temperature shift-down. A super-shift analysis with specific antibodies to the Rb family proteins and CDK2 showed that complex B was mostly shifted-up by p130 antibody. The complex A was shifted-up by anti-p107 and weakly by anti-p130 antibody ( Figure 9B ). The anti-CDK2 antibody completely shifted up complex A, while it did not affect the others. Based on the above experiments and a report from others (Cobrinik et al., 1993) , we propose that complex A contains mainly p107/ CDK2/cyclin A/E2F4 and a lesser amount of p130/ CDK2/cyclinA/E2F4. Complex B contains p130/E2F, while complex C represents free E2Fs without binding to the Rb family proteins. In accordance with the results of immunoprecipitation, these results demonstrate that the p107 complex with cyclin A/CDK2/ E2F4 was the main E2F complex in cycling cells. After the temperature shift-down, the p107/cyclinA/CDK2/ E2F4 complex disappeared and p130/E2Fs became the most prominent complex that was followed by the disappearance of free E2Fs.
To further identify which E2F family members formed complexes with p130, we performed EMSA of immunoprecipitation-purified p130 using the same E2F consensus binding sequence as a probe (Figure 10) . The results showed that at the non-permissive temperature p130 species formed a major complex with E2F4 as determined by super-shifting with E2F4 antibody. In contrast, at the permissive temperature, p130 species formed two different size classes of complexes. The anti-E2F1 and E2F4 antibodies produced super-shifted bands at different positions as slow-migrating complexes. The identify of fast-migrating complex is not known. In agreement with the results of Figure 9 E2Fs make complexes mainly with p130/S-130 in S138V cells cultured at permissive temperature. (A) Sneo or S138V cells were cultured at the permissive temperature for the indicated times. The cell lysates were subjected to gel shift assay with Figure 10 Super gel-shift assay showing that p130/S-p130 interacts with both E2F1 and E2F4 at the permissive temperature. The S138V cells cultured at the non-permissive (H) or permissive temperature (L) for 24 h were lysed and immunoprecipitated with anti-p130 antibody (C-20). The precipitates were used for super gel shift assay with 32 P-end labeled fragment from DHFR promoter. The antibodies, E2F1 (KH95) and E2F4 (C-108) were used for super-shift assay p130 mediates p53-induced cell cycle arrest C-F Gao et al immunoprecipitation/Western blotting, this experiment also showed that p130 can form complexes with both E2F1 and E2F4.
Overexpression of E1A 12S and E2F1 abrogated p53-induced cell cycle arrest
If p130 and E2F1 are involved in p53-induced cell cycle arrest, then the overexpression of E1A or E2F1 should abrogate the cell cycle arrest. The infection of adenovirus harboring E1A (12 S) or E2F1 to S138V cells effectively abrogated p53-induced cell cycle arrest as detected by FACS analysis, while the infection of control virus did not affect the cell cycle distribution (Table 1 ). This result further supports the idea that p53-induced cell cycle arrest is mediated through, at least partly, the p130/E2F1 pathway.
Discussion
In this study, we examined the role of p130 in p53-induced cell cycle arrest in Saos2 cells, an Rb-defective cell line. The results obtained support the idea that p130 can compensate for Rb functions in mediating p53-induced cell cycle arrest. Although it was controversial whether Rb is the only player of the Rb family proteins mediating DNA damage-induced G1 arrest in MEF cells (Slebos et al., 1994; Harrington et al., 1998) , several lines of evidence suggest that p53 does induce cell cycle arrest in the absence of Rb in various cell type (Bates et al., 1998; Chen et al., 1996) . The overexpression of p53 induces either cell cycle arrest or apoptosis in Rb-defective Saos2 cells, depending on the p53 protein level or experimental conditions (Diller et al., 1990; Bates et al., 1998; Chen et al., 1996) . We previously reported that the activation of ts p53Val138 in Saos2 cells mainly induces cell cycle arrest at both the G1 and G2 phases (Yamato et al., 1995) . Further we observed that the cell cycle arrest was reversible after p53 inactivation.
Adenovirus E1A, as well as the SV40 T antigen, and E7 of human papiloma virus (Chellappan et al., 1992) forms complexes with Rb family proteins and interferes with their cell cycle regulation activity (Whyte et al., 1988; Wang et al., 1993; Li et al., 1993) . The rescue of cell cycle arrest by ectopic expression of E12A (12S) suggested an essential role of Rb family proteins in the p53-induced cell cycle arrest. E2F family proteins play essential roles in cell cycle progression (Gaubatz et al., 2000; Wu et al., 2001) , while Rb family proteins regulate cell growth mainly by forming complexes with E2F family proteins (Hurford et al., 1997; Dyson, 1998) . Both immunoprecipitation and gel shift assays indicated that p130 was the prominent known Rb family protein detected in E2Fs complexes in the arrested cells, while the p107/E2F complex was detected only in cycling cells. These results suggest that p130 played a pivotal role in p53-induced cell cycle arrest in Saos2 cells.
The interaction of Rb with E2F family proteins is regulated by its phosphorylation state. P130 is a phosphoprotein whose phosphorylation is cell cycleregulated (Baldi et al., 1995; Mayol et al., 1995; Hansen et al., 2001) . In cycling cells, p130 exists in multiple phosphorylation forms, depending on the cell types or cell cycle stages. Serum starvation induces the accumulation of a less phosphorylated p130 form 1 and form 2 that form complexes with E2F4 and lead to cell cycle exit (Mayol et al., 1996) . In cycling S138V cells, p130 was detected as two phosphorylated forms, both of which can form complexes with E2F4 and cyclin A/CDK2 complex. Upon p53 activation, two phosphorylated forms of p130 decreased and two differently phosphorylated and truncated p130 (Sp130) forms were produced. These truncated p130 forms were detected by two different p130 antibodies, but not anti-p107 antibodies, or anti-Rb antibodies, excluding the possibility that they represented a crossreaction to p107 or pRb. Furthermore, the S-p130 was co-immunoprecipitated with viral oncoproteins and E2Fs proteins, suggesting the existence of the functional pocket domains that characterize the Rb family proteins.
The results that the p53-specific induction of S-p130 was not limited to the cell type of Saos2 cells or to the ts p53 gene lead us to identify a p53-responsive sequence in the intron 4, which suggested that p130 was a p53 target gene. Further, the results of RT -PCR suggested that the S-p130 was induced by p53 at transcriptional level. We observed a p53-dependent new transcript which contained the sequence of the 395 fragment spanning the intron 4 and the adjacent exon 5. Since (1) all three reading frames of the intron portion of this 395 bp fragment had stop codons; and (2) there was only one AUG codon at +12 within the exon 5, the reading frame of which was in accordance with that of the p130 protein, these results together suggested that S-p130 was a short form of p130 truncated with the first 216 N-terminal amino acids. The calculated molecular weight (105 kDa) of this protein just coincides with the value observed in the SDS -PAGE analysis of S-p130.
P130 and S-p130 showed subtle differences in their binding affinity to cyclin A. At the permissive temperature, the interaction of cyclin A to intact p130 was weak because of p21 induction, but it was detectable. Whereas S-p130 completely lost its binding to cyclin A as proved by co-immunoprecipitation analysis. This result was consistent with the report that a second conserved domain in the N-terminal portion of p130 and the spacer domain are required for p130 mediates p53-induced cell cycle arrest C-F Gao et al its interaction with cyclin A (Castano et al., 1998) . The p130 mutant that loses cyclin binding activity (deleted from 620 to 697) is more potent than wild-type p130 in the growth suppression of Saos2 cells (Lacy and Whyte, 1997) . In the present study, S-p130 lost the binding affinity to cyclin A, while retained a strong binding activity to E2F1 and E2F4. It is possible that the loss of cyclin A binding activity may lead to constitutive activation of S-p130 in forming complexes with E2F proteins. Although no differential binding activity of p130 and S-P130 to E2F family proteins was detected, S-p130 was the main pocket protein in E2F complexes because of its higher protein levels in the later stage of growth arrest (Figure 2) . We detected the strong binding of both p130 and Sp130 to E2F1 and E2F4 by either immunoprecipitation or gel shift assays. The abrogation of cell cycle arrest by ectopic overexpression or gel shift assays. The abrogation of cell cycle arrest by ectopic overexpression of E2F1 further indicates that E2F1 is involved in p130-mediated, p53-induced cell cycle arrest. This result is also consistent with a previous report that the overexpression of E2F1 rescues p130-induced G1 arrest in Saos2 cells (Claudio et al., 1996) . At first glance, this seems to disagree with the current idea that p130 binds only to E2F4 and E2F5 (Hijmans et al., 1995; Vairo et al., 1995; Dyson, 1998) . However, all the previous reports were carried out in systems independent of p53 activation. In our system, the induction of p21 disrupted the complex of p130 and cyclin A/CDK2 and may possibly block cdk2-dependent phosphorylation of p130 (Cheng et al., 2000; Hansen et al., 2001 ). The dissociation, or change of phosphorylation status of p130, may contribute to the enhancement of its affinity to E2F1. The interaction between p130 and E2F4 was also detected at the permissive temperature and to a lesser extent at the non-permissive temperature. No binding of p130 or S-p130 to other E2F family members was detected, suggesting the importance of E2F1 in p53-induced cell cycle arrest.
At the non-permissive temperature, p130 can exist in the E2F4/cyclinA/CDK2 complex and may represent an intermediate stage leading to the release of E2F4 (Shiyanov et al., 1996; Woo et al., 1997) . Alternately, p130 may change the substrate specificity of cyclin A/ CDK2 and block its activity to phosphorylate E2F1/ DP1 (Hauser et al., 1997) . Since the cyclin A/CDK2 negatively regulates E2F1 DNA binding activity (Krek et al., 1995; Dynlacht et al., 1997) , the complex formation of cyclin A/CDK2 and p107 or p130 may be necessary for the progression of the cell cycle into the S phase. At the permissive temperature, the complex was disrupted by p21 that displaced p130 from the complex. Such disruption was also reported in TGF-b and glucocorticoids-induced cell cycle arrest (Yoo et al., 1999; Smith et al., 2000) . The p21 mutant defective in the complex disruption also loses the inhibition of E2F-regulated transcription, further suggesting its importance in p21 mediated cell cycle arrest (Robles et al., 1998) . The complex disruption in our system may contribute to the release of p130 from the complex and the binding of p130 to E2F1. p130 also has the ability to recruit HDAC and CtBP corepressor to its E2F complex (Stiegler et al., 1998; Meloni et al., 1999) . Therefore, the formation of p130/ E2F1 and p130/E2F4 complexes may block S phase entry by repressing the expression of genes required for S phase entry. This result is consistent with a recent report that E2F4 was necessary for pocket proteinmediated G1 arrest in response to p16
INK4a (Gaubatz et al., 2000) . The p130/E2F4 complex was also reported to mediate p53-induced G2 arrest by repressing the cdc2 promoter (Taylor et al., 2000) . Whether or not p130/E2F4 complex contributes to G2 arrest in this system needs further study.
Based on our results and the reports from others, we propose a model for p53-induced cell cycle arrest in Saos2 cells (Figure 11 ). The induction of p21 by p53 disrupts the complex of p130 and cyclin A/CDK2. The released p130 induced an early phase cell cycle arrest by forming complexes E2F1 and E2F4 (not shown in this model). The activation of p53 also directly induces an N-terminal truncated form of p130 (S-p130) that contributes to permanent cell cycle arrest by binding to E2F1 and E2F4.
Materials and methods
Cell culture, transfection and chemicals S138V cells carrying CMV promoted human p53138Val mutant and Sneo cells carrying the CMV vector with neomycin-resistant gene were established previously (Yamato et al., 1995) . The 293T cell line was a kind gift from Dr S Ishii, Riken, Tsukuba, Japan. The cells were grown in Dulbecco's modified Eagle's medium (Nissui Pharmaceutical Co. Ltd, Tokyo, Japan) supplemented with 10% fetal bovine Figure 11 Schematic model of p53-induced growth arrest in Rbdefective Saos2 cells p130 mediates p53-induced cell cycle arrest C-F Gao et al serum at 37.58C. For activation of p53, the cells were transferred to 32.58C for various times. Cells were transfected by the calcium phosphate precipitation method (Chen and Okayama, 1987) . Precipitates were left on cells for 12 h before washing with 0.1% EDTA/PBS, and the cells were refed with fresh medium.
The purified SV40 large T-antigen (Tag) was obtained from Molecular Biology Resource Inc. (l-phosphatase was from New England Biolabs., Inc, MA, USA).
Immunoprecipitation and immunoblotting
Cell lysates were prepared as described (Thomas et al., 1998) . Briefly, cells were lysed in RIPA buffer (20 mM Tris.HCl, pH 7.6, 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM (b-glycerophosphate, 1 mM Na 3 VO 4 .4H 2 O, 5 mM Na 4 P 2 O 7 .10H 2 O containing protease inhibitor Complete TM (Boehringer-Mannheim, Germany). The lysate was centrifuged at 10 000 g for 20 min to remove the cellular debris. The supernatant containing 1 mg protein was pre-cleared with 1 mg of rabbit or mouse IgG (Santa Cruz, CA, USA) and 20 ml protein A/G-sepharose (Amersham Pharmacia Biotech, Inc., Tokyo) for 1 -2 h. Immunoprecipitation was carried out with 1 mg antibody and then with 20 ml protein A/G-sepharose. After extensive washing with RIPA buffer, the immunoprecipitates were released from beads by boiling in 16loading buffer. One-third of the supernatant was used for immunoblotting.
Immunoprecipitates or whole cell extracts (20 mg) were resolved by SDS -PAGE and transferred onto PVDF filters (Nihon Millipore, Tokyo, Japan). The filter was blocked with 5% skim milk in 16TTBS (20 mM Tris-HCl pH 7.6, 137 mM NaCl and 0.1% Tween-20), incubated with either one of the following first antibodies: anti-p53 (PAb1801), anti-MDM2 (SMP14), anti-p21 (C-19), anti-Rb (C-15), anti-p130 (monoclonal antibody, C-20), anti-p107 (C-18), anti-E2F1 (C-20), anti-E2F4 (C-20), anti-cyclin A (BF683), anti-cyclin D1 (H-295), anti-cyclin D3 (C-16), anti-cyclin E (M-20), anti-cyclin E (C-19), anti-CDC2 p34 (17), anti-CDK2 (M2), anti-CDK4 (C-22), or anti-CDK6 (C-21) antibodies from Santa Cruz Biotechnology. The antibodies, anti-Rb2 (p130) and anticyclin A were from Transduction Laboratory and anti-E2F1 (KH95) and anti-HA antibody were from Pharmingen. Antibodies against SV40 Tag (Ab-2) and Adenovirus 2 E1A (Ab-1) were from Calbiochem. Anti-ubiquitin antibody was from MBL (Nagoya, Japan), After 1 h, the membrane was washed with 16TTBS and incubated with horseradishconjugated second antibodies and detected with an ECL detecting system (Amersham, Pharmacia Biotech).
RT -PCR
Total cellular RNAs were extracted from S138V cells cultured for various times at the permissive temperature, as described previously (Gao et al., 1999) . The cDNA was synthesized with MLV reverse transcriptase with a random primer using Superscript TM (Life Technologies, Rockville, MD, USA) as recommended by the supplier. Oligonucleotide primers for PCR amplification were as follows: forward primers in the intron 4 of p130 were with sequences of GAACTCAGATCTCCTGGTTC (I 4U ) and AGACAGGAA-GATCCCTTGAG(I 4D ). Two exon primers in exon 2 (forward) (E 2 ) and exon 5 (reverse) (E 5 ) were TTCATTGGT-TAGCATGTGCC and CGATTAGAACACTGAAGTGC, respectively. The primers used to amplify the region containing tandem consensus p53 binding site were I 4U for forward and CAAGCTACAAAGCCCATCAC(I 4MAS ) for reverse.
Intron 1, 2 and 3 primers at positions close to each downstream exon were GAGCGTATGAGATAGGGTCA (I 1 ), TGAATTAGGATCAGAGG (I 2 ), and TCTCTCCCT-TTAACTGTGGG (I 3 ), respectively. PCR amplification was carried out with initial denaturation at 948C, followed by 35 cycles of 30 s at 948C and 30 s at 588C.
Luciferase assay
The PGL3-promoter vector (Promega Co.,) was modified to measure the p53-dependent promoter activity to remove a single copy of consensus p53 binding sequence between the unique NheI and XhoI sites. The plasmid DNA was digested by these enzymes, blunt-ended by a filling reaction with Klenow fragment and recircularized to make pGL3/luc-NX. Further, the MluI site of pGL3luc-NX was replaced with the EcoRI site by digesting with MluI, filling up with Klenow fragment, followed by religation in the presence of EcoRI linker to make pGL3/E/luc-NX. PCR-amplified DNA fragments to be tested for promoter activity were first cloned in the T/A cloning vector (Invitrogen), digested with EcoRI and inserted into the EcoRI site of pGL3/E/luc-NX. To test the 30 nucleotides of the p53 binding sequence within the intron 4 of the p130, the wild-type oligonucleotide (sense: ACACCAACAAGCCTAAACTTGTTACTGGT and anti-sense: CCAGTAACAAGTTTAGGCTTGTTGGT-GTG) and the mutant oligonucleotide (sense: CACACC-AA*AAAGCCTAAACTT*CTTACTGT and antisense: AC-CAGTAA*GAAGTTTAGGCTT*TTTGGTGTG: *mutated bases) were synthesized, annealed and inserted at the EcoRI site of pGL3/E/luc-NX after the EcoRI site of pGL3/E/luc-NX was blunt-ended as described previously (Tsutsumi-ishii et al., 1995) , yielding p53-BS(W)-Luc and p53BS(M)-Luc. The region within the intron 4 which contained the p53 binding sequence was PCR amplified with I 4U and I 4MAS primers, inserted into T/A plasmid (Invitrogen), and excised with EcoRI. The resulting EcoRI fragment was inserted at the EcoRI site of pGL3/E/luc-NX, yielding I 4 -Luc. RGCLuc was also used as a positive control (Haupt et al., 1995) .
For the measurement of p53-dependent promoter activity, S138V cells were transfected in 60 mM plates with 1 mg of each reporter plasmid by the calcium phosphate method (Chen and Okayama, 1987) . Four hours after the transfection, the cells were washed with PBS containing 0.1% EDTA and one set of the cultures was incubated at 37.58C and the other set at 32.58C. The preparation of cell extract at 48 h after transfection and measurement of luciferase activities were described previously (Yageta et al., 1999) . Luciferase activities relative to that of RGC -Luc were calculated as described previously (Oda et al., 2000) .
E2F gel-shift assay E2F-DNA binding assay was done as described previously (Ikeda et al., 1996) . Whole cell extracts or p130 immunoprecipitates were incubated with 32 P-end-labeled HaeIII -HindIII fragment, spanning the region 7103 to 723 relative to the dehydrofolate reductase (DHFR) translation start site isolated from the DHFR-chloramphenicol acetyltransferase (CAT) plasmid. Cell extracts were incubated for 20 min at room temperature in 20 mM HEPES, pH 7.9, 40 mM KCl, 6 mM MgCl 2 , 1 mM dithiothreitol, 0.1% Nonidet P-40, 10% glycerol, bovine serum albumin at 30 mg for 500 ng of sonicated salmon sperm DNA/0.1 ng of 32 P-labeled probe, followed by electrophoresis in 5% polyacrylamide gels (acrylamide: bisacrylamide, 75 : 1) in TBS (50 mM Trisborate/1 mM EGTA) containing 5% glycerol.
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Gel shift assay of immunoprecipitated p130 complex
The preparation of immunoprecipitate for the gel-shift assay was done as described previously (Ikeda et al., 1996) . Briefly, whole cell lysate (100 mg in RIPA buffer) was mixed with 1 mg of anti-p130 antibody linked to magnetic beads in 16shift buffer (20 mM HEPES, pH 7.9, 40 mM KCl, 6 mM MgCl 2, 1 mM dithiothreitol and 0.1% Nonidet P-40 supplemented with proteinase inhibitor Complete TM , Boehringer Mannheim, Germany) for 1 -2 h at 48C with gentle rotation. The beads were recovered using a magnetic stand, washed three times with ice-cold 16gel-shift buffer, and then treated with 16 ml of 0.8% deoxycholate (DOC) to dissociate p130 from E2F complexes on ice. After neutralization with 4 ml of 6% Nonidet P-40, 4 ml of the supernatant was used for the gel-shift assay.
Cell cycle analysis
Cells were trypsinized and collected by centrifuging at low speed (300 g) for 5 min. The samples were prepared and stained with propidium iodide using the Cycle Testing Plus DNA Reagent Kit (Becton Dickinson, Mountain View, CA, USA) according to the instruction from the supplier. DNA contents were analysed by a FACS analyser (Becton Dickinson FACScan).
Adenovirus infection
All infections were performed at an input multiplicity of 100 plaque-forming units/cell as described previously (Terada et al., 1997) . The AdE2F1 virus (Schwarz et al., 1995) , AdE1A12S/E1B-virus (a kind gift from Dr J Nevins) and Adb-gal (Miyake et al., 1996) as a control were used. For infection of S138V cells, 16105 cells/34 mm dish were grown at 32.58C for 12 h and infected with viruses for 1 h in PBS, and then re-fed with fresh medium. After 24 h of infection, the cells were collected and subjected to FACS analysis as described above.
